122-85-0
Chemical Structure
N-(4-Formylphenyl)acetamide
Synonym(s): 4-Acetamidobenzaldehyde
- CAS No.: 122-85-0
- Formula:C9H9NO2
- Molecular Weight:163.18
IUPAC Name: N-(4-formylphenyl)acetamide
InChIKey: SKLUWKYNZNXSLX-UHFFFAOYSA-N
SMILES: O=CC1=CC=C(NC(C)=O)C=C1
Biological Activity: N-(4-Formylphenyl) acetamide (4-Acetamidobenzaldehyde) is an organic ligand bearing aldehyde and acetamide functional groups. N-(4-Formylphenyl) acetamide can be used to functionalize Fe3O4@SiO2 nanoparticles for selective fluorescence quenching detection of Hg2+. N-(4-Formylphenyl) acetamide serves as a precursor for the synthesis of benzimidazole, benzothiazole and Schiff base derivatives, which exhibit antioxidant, AChE/BChE inhibitory and DNA-binding activities. N-(4-Formylphenyl) acetamide can be applied in studies related to Alzheimer's disease[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
N-(4-Formylphenyl)acetamide | N-(4-Formylphenyl) acetamide (4-Acetamidobenzaldehyde) is an organic ligand bearing aldehyde and acetamide functional groups. N-(4-Formylphenyl) acetamide can be used to functionalize Fe3O4@SiO2 nanoparticles for selective fluorescence quenching detection of Hg2+. N-(4-Formylphenyl) acetamide serves as a precursor for the synthesis of benzimidazole, benzothiazole and Schiff base derivatives, which exhibit antioxidant, AChE/BChE inhibitory and DNA-binding activities. N-(4-Formylphenyl) acetamide can be applied in studies related to Alzheimer's disease. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Heidari A, et al. 4-Acetamidobenzaldehyde-Functionalized FeO@SiO Fluorescent Nanocomposite Probe for Detection of Hg in Aqueous Solution. Journal of fluorescence. 2017 Mar;27(2):659-667. [Content Brief]
- [2]. Murtaza S, et al. 4-Acetamidobenzaldehyde derivatives as biological active candidates; synthesis, anti-oxidant, Anti-Alzheimer and DNA binding studies[J]. Letters in Drug Design & Discovery, 2018, 15(9): 957-968.
